Clinical Trial

Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer

Name: Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer — clinical trial record (NCT07007910)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a phase I, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK（pharmacokinetics） and PD（pharmacodynamics） of HSK46575 when given orally in patients with metastatic castration-resistant prostate cancer.

Trial Details

NCT Number	NCT07007910
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	m CRPC
Enrollment	90 participants
Start Date	2024-12-18
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2025-06-06